Epigenetics Market is Expected to Reach $4.3 Billion | MarketsandMarkets.
January 12, 2024 07:30 ET
|
MarketsandMarkets Research Pvt. Ltd.
Chicago, Jan. 12, 2024 (GLOBE NEWSWIRE) -- Epigenetics market in terms of revenue was estimated to be worth $1.8 billion in 2023 and is poised to reach $4.3 billion by 2028, growing at a CAGR of...
K36 Therapeutics Named “Overall BioPharma Startup of the Year” By BioTech Breakthrough
November 08, 2023 08:05 ET
|
BioTech Breakthrough
CAMBRIDGE, Mass., Nov. 08, 2023 (GLOBE NEWSWIRE) -- K36 Therapeutics (“K36”) has been selected as “Overall BioPharma Startup of the Year” in the third annual BioTech Breakthrough Awards Program...
Cyclacel Pharmaceuticals Reports Second Quarter Financial Results and Provides Business Update
August 09, 2023 16:05 ET
|
Cyclacel
- Key Catalysts ahead with Multiple Value Generating Readouts-- Expects to Release Phase 1/2 Data with Oral Fadraciclib -- Signals of Single-agent Efficacy with Oral Plogosertib -- Management to Host...
Epigenetics Market is Expected to Reach $3.9 billion | MarketsandMarkets.
July 03, 2023 08:30 ET
|
MarketsandMarkets Research Pvt. Ltd.
Chicago, July 03, 2023 (GLOBE NEWSWIRE) -- In the near future, the epigenetics industry is poised for remarkable advancements and transformative impact in various fields. Epigenetics, the study of...
Fluidigm Announces Second Quarter 2020 Financial Results
August 06, 2020 16:05 ET
|
Fluidigm Corporation
Second Quarter Revenue Decreased 8 Percent to $26.1 Million Filed for FDA Emergency Use Authorization for COVID-19 Saliva-based Test Multi-Site U.S. Study of COVID-19 Patients Utilizes Mass...
Fluidigm to Present at Upcoming Health Care Investor Conferences
May 13, 2020 16:02 ET
|
Fluidigm Corporation
SOUTH SAN FRANCISCO, Calif., May 13, 2020 (GLOBE NEWSWIRE) -- Fluidigm Corporation (Nasdaq:FLDM), an innovative biotechnology tools provider with a vision to improve life through comprehensive...
Fluidigm and the Icahn School of Medicine at Mount Sinai Collaborate on Landmark Single-Cell Study of the Human Epigenome
August 27, 2019 08:30 ET
|
Fluidigm Corporation
SOUTH SAN FRANCISCO, Calif., Aug. 27, 2019 (GLOBE NEWSWIRE) -- Fluidigm Corporation (NASDAQ:FLDM), an innovative biotechnology tools provider with a vision to improve life through comprehensive...
Cancer Biomarkers Market To Reach USD 32.25 Billion By 2026 | Reports And Data
May 21, 2019 12:16 ET
|
Reports And Data
High target disease prevalence, product launches, increasing strategic developments such as partnerships and agreements, favourable research funding scenario are key factors contributing to high CAGR...
Fluidigm Announces First Multimodal Single-Cell Application for the C1
July 10, 2018 08:30 ET
|
Fluidigm Corporation
SOUTH SAN FRANCISCO, Calif., July 10, 2018 (GLOBE NEWSWIRE) -- Fluidigm Corporation, a leader in mass cytometry and microfluidics technologies, today announced a new bimodal single‑cell application...
Elsevier Launches New Stem Cell Book Series
May 23, 2017 04:00 ET
|
Elsevier, Inc.
CAMBRIDGE, MA--(Marketwired - May 23, 2017) - Elsevier, the information analytics company specializing in science and health, today announced a new book series, Advances in Stem Cells and their...